Log in to save to my catalogue

Normal C-reactive protein in active psoriatic arthritis: results from real-world clinical practice

Normal C-reactive protein in active psoriatic arthritis: results from real-world clinical practice

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c1cb3433aad34d0eade5d1ce52ddb1ca

Normal C-reactive protein in active psoriatic arthritis: results from real-world clinical practice

About this item

Full title

Normal C-reactive protein in active psoriatic arthritis: results from real-world clinical practice

Publisher

London, England: SAGE Publications

Journal title

Therapeutic advances in musculoskeletal disease, 2022, Vol.14, p.1759720X221122417-1759720X221122417

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

More information

Scope and Contents

Contents

Background:
The value of normal C-reactive protein (CRP) in psoriatic arthritis (PsA) is debatable.
Objectives:
To test the hypothesis that CRP is frequently normal in contemporary real-world PsA patients, despite active disease.
Design:
In this cross-sectional study, patients were divided into two groups: CRP ⩽ 0.5 mg/dl (normal) an...

Alternative Titles

Full title

Normal C-reactive protein in active psoriatic arthritis: results from real-world clinical practice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c1cb3433aad34d0eade5d1ce52ddb1ca

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c1cb3433aad34d0eade5d1ce52ddb1ca

Other Identifiers

ISSN

1759-720X

E-ISSN

1759-7218

DOI

10.1177/1759720X221122417

How to access this item